HomeOGN • NYSE
add
Organon & Co
Nakaraang pagsara
$11.04
Sakop ng araw
$10.83 - $11.21
Sakop ng taon
$10.83 - $23.10
Market cap
2.80B USD
Average na Volume
4.19M
P/E ratio
3.26
Dividend yield
10.32%
Primary exchange
NYSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 1.59B | -0.38% |
Gastos sa pagpapatakbo | 598.00M | 14.78% |
Net na kita | 109.00M | -80.04% |
Net profit margin | 6.85 | -79.95% |
Kita sa bawat share | 0.90 | 2.27% |
EBITDA | 375.00M | -17.40% |
Aktuwal na % ng binabayarang buwis | 15.50% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 675.00M | -2.60% |
Kabuuang asset | 13.10B | 8.65% |
Kabuuang sagutin | 12.63B | 4.13% |
Kabuuang equity | 472.00M | — |
Natitirang share | 257.95M | — |
Presyo para makapag-book | 6.03 | — |
Return on assets | 5.76% | — |
Return on capital | 7.95% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 109.00M | -80.04% |
Cash mula sa mga operasyon | 390.00M | -1.76% |
Cash mula sa pag-invest | -296.00M | -265.43% |
Cash mula sa financing | -82.00M | -6.49% |
Net change in cash | -88.00M | -131.54% |
Malayang cash flow | 268.75M | -27.88% |
Tungkol
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but gets a third of its revenue from the United States. Wikipedia
Itinatag
1923
Headquarters
Website
Mga Empleyado
10,000
